Prognia
Drug Database
🇺🇸US · FDA ApprovedDiscontinuedANDA212663-001

ABACAVIR SULFATE AND LAMIVUDINE(ABACAVIR SULFATE)

Manufacturer: MACLEODS PHARMS LTD

FDA Approval: 19/12/2024

Route: ORAL · TABLET

Active Ingredients

ABACAVIR SULFATE EQ 600MG BASE; LAMIVUDINE 300MG

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ABACAVIR SULFATE AND LAMIVUDINE — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.